amifostine anhydrous has been researched along with Cholera Infantum in 7 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-dose melphalan (HDM) followed by autologous hematopoietic cell transplantation (auto-HCT) remains the standard-of-care therapy for multiple myeloma (MM) even with the availability of proteasome inhibitors and immunomodulatory drugs." | 3.88 | Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma. ( Bashir, Q; Caimi, P; Champlin, R; Cooper, B; Covut, F; Creger, R; de Lima, M; Delgado, R; Gupta, V; Lazarus, HM; Malek, E; Qazilbash, M; Rondon, G; Vatsayan, A, 2018) |
| "Mucositis is a significant complication of cancer therapy, with important clinical and economic implications." | 2.43 | Amifostine in the management of radiation-induced and chemo-induced mucositis. ( Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM, 2006) |
| "Sodium selenite was ineffective in reducing tetraplatin-induced damage when administered 4 hr before tetraplatin at doses of 0." | 1.28 | Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat. ( Carfagna, PF; Chaney, SG; Chang, J; Holbrook, DJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malek, E | 1 |
| Gupta, V | 1 |
| Creger, R | 1 |
| Caimi, P | 1 |
| Vatsayan, A | 1 |
| Covut, F | 1 |
| Bashir, Q | 1 |
| Champlin, R | 1 |
| Delgado, R | 1 |
| Rondon, G | 1 |
| Cooper, B | 1 |
| de Lima, M | 1 |
| Lazarus, HM | 1 |
| Qazilbash, M | 1 |
| Bensadoun, RJ | 1 |
| Schubert, MM | 1 |
| Lalla, RV | 1 |
| Keefe, D | 1 |
| Treskes, M | 1 |
| van der Vijgh, WJ | 1 |
| Prasanna, PG | 1 |
| Uma Devi, P | 1 |
| Raza, A | 1 |
| Qawi, H | 1 |
| Lisak, L | 1 |
| Andric, T | 1 |
| Dar, S | 1 |
| Andrews, C | 1 |
| Venugopal, P | 1 |
| Gezer, S | 1 |
| Gregory, S | 1 |
| Loew, J | 1 |
| Robin, E | 1 |
| Rifkin, S | 1 |
| Hsu, WT | 1 |
| Huang, RW | 1 |
| Hartmann, JT | 1 |
| von Vangerow, A | 1 |
| Fels, LM | 1 |
| Knop, S | 1 |
| Stolte, H | 1 |
| Kanz, L | 1 |
| Bokemeyer, C | 1 |
| Carfagna, PF | 1 |
| Chaney, SG | 1 |
| Chang, J | 1 |
| Holbrook, DJ | 1 |
2 reviews available for amifostine anhydrous and Cholera Infantum
| Article | Year |
|---|---|
Amifostine in the management of radiation-induced and chemo-induced mucositis.
Topics: Amifostine; Antineoplastic Agents; Combined Modality Therapy; Esophagitis; Evidence-Based Medicine; | 2006 |
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
Topics: Amifostine; Animals; Bone Marrow Diseases; Carboplatin; Cisplatin; Ear Diseases; Gastrointestinal Di | 1993 |
1 trial available for amifostine anhydrous and Cholera Infantum
| Article | Year |
|---|---|
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2001 |
4 other studies available for amifostine anhydrous and Cholera Infantum
| Article | Year |
|---|---|
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.
Topics: Adult; Aged; Amifostine; Case-Control Studies; Combined Modality Therapy; Diarrhea; Disease-Free Sur | 2018 |
Modification of WR-2721 radiation protection from gastrointestinal injury and death in mice by 2-mercaptopropionylglycine.
Topics: Amifostine; Animals; Drug Therapy, Combination; Gastrointestinal Diseases; Mice; Mice, Inbred Strain | 1993 |
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols | 2000 |
Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Topics: Amifostine; Animals; Antineoplastic Agents; Antiviral Agents; Blood Urea Nitrogen; Creatinine; Ditio | 1990 |